
    
      A Phase I Randomised, Placebo-Controlled, Double-Blind Study in Hypertensive Patients of the
      Blood Pressure Interaction between TC-5214 and Anti-Hypertensive Medications (Calcium Channel
      Blockers, Beta Blockers, and ACE Inhibitors)
    
  